Provided by Tiger Trade Technology Pte. Ltd.

LISATA THERAPEUTICS INC

1.55
+0.430038.39%
Post-market: 1.640.0900+5.81%19:59 EDT
Volume:7.12M
Turnover:10.96M
Market Cap:13.97M
PE:-0.94
High:1.79
Open:1.11
Low:1.10
Close:1.12
52wk High:5.07
52wk Low:0.9875
Shares:9.01M
Float Shares:7.11M
Volume Ratio:103.53
T/O Rate:100.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6418
EPS(LYR):-1.9100
ROE:-101.66%
ROA:-56.74%
PB:1.69
PE(LYR):-0.81

Loading ...

Company Profile

Company Name:
LISATA THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
1980
Employees:
21
Office Location:
110 Allen Road,2nd Floor,Basking Ridge,New Jersey,United States
Zip Code:
07920
Fax:
- -
Introduction:
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Directors

Name
Position
David J. Mazzo
Chief Executive Officer,Director and President
Gregory B. Brown
Chairman
Cynthia L. Flowers
Independent Director
Heidi Henson
Independent Director
Mohammad Azab
Independent Director
Steven M. Klosk
Independent Director

Shareholders

Name
Position
David J. Mazzo
Chief Executive Officer,Director and President
James Nisco
Senior Vice President Finance and Treasury and Chief Accounting Officer
Tariq Imam
Senior Vice President, Business Development and Operations and General Counsel
Kristen K. Buck
Executive Vice President R&D and Chief Medical Officer